Hendrik Reynaert
Overview
Explore the profile of Hendrik Reynaert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
819
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lejeune A, Starkel P, Louvet A, Hittelet A, Bazille C, Bastens B, et al.
Transl Gastroenterol Hepatol
. 2025 Feb;
10:3.
PMID: 39944578
Background: Keratin 7 positive (K7) cells are considered to be activated in case of impaired hepatocyte replication. Their exact role and their interaction with hepatocytes and macrophages also implicated in...
2.
Delaleeuwe I, Aoun J, Reynaert H, Gkolfakis P, Eisendrath P
Ann Gastroenterol
. 2025 Jan;
38(1):41-50.
PMID: 39802288
Background: Various endoscopic treatment options are available for managing colonic diverticular bleeding (CDB). We conducted a systematic review and meta-analysis to assess the effectiveness of these endoscopic interventions in achieving...
3.
Merens V, Knetemann E, Gurbuz E, De Smet V, Messaoudi N, Reynaert H, et al.
JHEP Rep
. 2025 Jan;
7(1):101223.
PMID: 39758511
Background & Aims: The progression of chronic liver disease (CLD) is characterized by excessive extracellular matrix deposition, disrupting hepatic architecture and function. Upon liver injury, hepatic stellate cells (HSCs) differentiate...
4.
Hens B, Reynaert H
Cureus
. 2024 Dec;
16(11):e73129.
PMID: 39650932
A cholecystocolonic fistula (CCF) is a rare cause of chronic diarrhoea. It most often occurs in elderly women as a result of chronic inflammation due to gallstone disease or, rarely,...
5.
Cools L, Dastjerd M, Smout A, Merens V, Yang Y, Reynaert H, et al.
Biofabrication
. 2024 Jun;
16(3).
PMID: 38865994
The lack of adequate humanmodels that recapitulate the cellular composition and response of the human liver to injury hampers the development of anti-fibrotic drugs. The goal of this study was...
6.
De Smet V, Gurbuz E, Eysackers N, Dewyse L, Smout A, Dastjerd M, et al.
JHEP Rep
. 2024 May;
6(5):101036.
PMID: 38694958
Background & Aims: Chronic liver disease (CLD) remains a global health issue associated with a significant disease burden. Liver fibrosis, a hallmark of CLD, is characterised by the activation of...
7.
Dirven I, Leclercq P, DHondt L, Delmotte V, Lefesvre P, Reynaert H, et al.
Acta Oncol
. 2024 Apr;
63:192-197.
PMID: 38619338
Background And Purpose: Primary angiosarcoma of the spleen (PAS), an exceptionally rare and aggressive neoplasm with high metastatic risk (70%-85%), is frequently diagnosed in an advanced or metastatic stage. It...
8.
Rosseel Z, Cortoos P, Jonckheer J, Cools W, Vinken M, Reynaert H, et al.
Nutrients
. 2023 Jun;
15(11).
PMID: 37299575
Background: Parenteral nutrition (PN) is often associated with liver dysfunction in the ICU, although other factors such as sepsis, acute heart failure (AHF), and hepatotoxic drugs can be equally present....
9.
van Os E, Cools L, Eysackers N, Szafranska K, Smout A, Verhulst S, et al.
Biomaterials
. 2022 Oct;
290:121817.
PMID: 36208587
Chronic liver disease can lead to liver fibrosis and ultimately cirrhosis, which is a significant health burden and a major cause of death worldwide. Reliable in vitro models are lacking...
10.
Peeters M, Schenk J, De Somer T, Roskams T, Locus T, Klamer S, et al.
J Hepatol
. 2022 Sep;
78(1):67-77.
PMID: 36075495
Background & Aims: HEV genotype (gt) 3 infections are prevalent in high-income countries and display a wide spectrum of clinical presentations. Host - but not viral - factors are reported...